Louise Hiller - Concepedia

Author

Louise Hiller

Also Known As

A M Wardley, Arriola, Larraitz, H M Earl, Helena Earl, Hiller, Louise, L HILLER, L Hiller, L. Hiller, L.H. Hiller, Lea Hiller

154

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

University of Warwick University of Birmingham Cancer Research UK Clinical Trials Unit University of Cambridge Edinburgh Cancer Research

About

Louise Hiller is an author at University of Warwick specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	26	2.8K
2	Health Sciences	4	4	154
3	Engineering	1	1	15
4	Natural Sciences	1	1	15
5	Nursing	1	1	64

Louise Hiller

Publications

11K

Citations

H-Index

Page 1

	Year	Citations
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation Ruth Tennant, Louise Hiller, Ruth Fishwick, Health and Quality of Life Outcomes	2007	4.8K
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients Hager R. Ali, Elena Provenzano, Sarah‐Jane Dawson, Annals of Oncology Breast OncologyCancer ImmunosurveillanceMedicineT-regulatory CellImmunology	2014	763
Multi-omic machine learning predictor of breast cancer therapy response Stephen‐John Sammut, Mireia Crispin‐Ortuzar, Suet‐Feung Chin, Nature	2021	586
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Daniele Bergamaschi, Milena Gasco, Louise Hiller, Cancer Cell Tumor BiologyOncologyMedicineApoptosisCell Death	2003	456
PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes H. Raza Ali, Silvia-Elena Glont, Fiona M. Blows, Annals of Oncology Breast OncologyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorBreast Cancer	2015	292
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial Helena Earl, Louise Hiller, Anne-Laure Vallier, The Lancet	2019	277
Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis K. Batta, Helen Goodyear, Celia Moss, The Lancet 1-Year AnalysisUncomplicated Childhood HaemangiomasPediatric NeurosurgeryPediatricsDermatology	2002	258
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo Alexandra Sullivan, Nelofer Syed, Milena Gasco, Oncogene Tumor BiologyTumor HeterogeneityMedicinePathologyCancer Genomics	2004	248
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers Chris Pepper, Thet Thet Lin, Guy Pratt, Blood	2008	239
Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer Christopher Poole, Helena Earl, Louise Hiller, New England Journal of Medicine	2006	189

Page 1